Medical News
Atacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis
New England Journal of Medicine - 22 Oct 2026 02:00
New England Journal of Medicine, Ahead of Print.
Sibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis
New England Journal of Medicine - 22 Oct 2026 02:00
New England Journal of Medicine, Ahead of Print.